Trafficking ofNMDAreceptors during status epilepticus: Therapeutic implications

Epilepsia

Volumn 54, Issue SUPPL. 6, 2013, Pages 78-80

  Wasterlain, Claude G ^a,b,c   Naylor, David E ^a,b,d   Liu, Hantao ^a,b   Niquet, Jerome ^a,b   Baldwin, Roger ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Acute seizures; Cholinergic seizures; Epilepsy; Hippocampus; Monotherapy; NMDA receptor; Receptor trafficking; Status epilepticus

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID;

ARTICLE; DENTATE GYRUS; DISEASE ASSOCIATION; DRUG EFFICACY; EPILEPTIC STATE; EPILEPTOGENESIS; EXCITOTOXICITY; GRANULE CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTIC EFFICACY; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; HIPPOCAMPUS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; RAT; STATUS EPILEPTICUS; ACUTE SEIZURES; CHOLINERGIC SEIZURES; EPILEPSY; MONOTHERAPY; RECEPTOR TRAFFICKING;

ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; N-METHYLASPARTATE; NEURONS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; STATUS EPILEPTICUS;

ACUTE SEIZURES; CHOLINERGIC SEIZURES; EPILEPSY; HIPPOCAMPUS; MONOTHERAPY; NMDA RECEPTOR; RECEPTOR TRAFFICKING; STATUS EPILEPTICUS;

EID: 84891531062     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12285     Document Type: Article

References (13)

1. Bertram EH, Lothman EW. (1990) NMDA receptor antagonists and limbic status epilepticus: A comparison with standard anticonvulsants. Epilepsy Res 5:177-184.
2. Frasca A, Aalbers M, Frigerio F, Fiordaliso F, Salio M, Gobbi M, Cagnotto A, Gardoni F, Battaglia GS, Hoogland G, Di Luca M, Vezzani A. (2011) Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis 43:507-515.
3. Fujikawa DG. (1995) Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36:186-195.
4. Mazarati AM, Wasterlain CG. (1999) N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 265:187-190.
5. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. (1998) Timedependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 814:179-185.
6. Mazarati AM, Baldwin RA, Sofia RD, Wasterain CG. (2000) Felbamate in experimental model of status epilepticus. Epilepsia 41:123-127.
7. Mazarati A, Bragin A, Baldwin R, Shin D, Wilson C, Sankar R, Naylor D, Engel J, Wasterlain CG. (2002) Epileptogenesis after selfsustaining status epilepticus. Epilepsia 43(Suppl. 5):74-80.
8. Naylor DE, Liu H, Wasterlain CG. (2005) Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 25:7724-7733.
9. Naylor DE, Liu H, Niquet J, Wasterlain CG. (2013) Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol Dis 54:225-238.
10. Prybylowski K, Fu Z, Losi G, Hawkins LM, Luo J, Chang K, Wenthold RJ, Vicini S. (2002) Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci 22:8902-8910.
11. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W, Investigators NETT. (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 366:591-600.
12. Wasterlain CG, Liu H, Mazarati AM, Baldwin RA, Shirasaka Y, Katsumori H, Thompson KW, Sankar R, Pereira de Vasconselos A, Nehlig A. (2000) Self-sustaining status epilepticus: A condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators. Epilepsia 41(Suppl. 6):S134-S143.
13. Wasterlain CG, Baldwin R, Naylor DE, Thompson KW, Suchomelova L, Niquet J. (2011) Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia 52(Suppl. 8):70-71.